Hans Hull
First SEC filing: June 2, 2020 · Latest: June 2, 2020
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2025 | PLRX | A | 40,150 | · | · | 251,708 Direct | +18.98% | Acquired | (price as of 2026-10-02) |
| Jan. 23, 2025 | PLRX | A | 80,300 | · | · | 80,300 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 17, 2025 | PLRX | S 10b5-1 | 15,936 | $11.20 | $178,483 | 211,558 Direct | -7.01% | Disposed | -90.8% (price as of 2026-10-02) |
| July 10, 2024 | PLRX | S 10b5-1 | 9,900 | $11.56 | $114,444 | 227,494 Direct | -4.17% | Disposed | -91.0% (price as of 2026-10-02) |
| July 9, 2024 | PLRX | A | 19,337 | · | · | 237,394 Direct | +8.87% | Acquired | (price as of 2026-10-02) |
| Jan. 23, 2024 | PLRX | A | 31,500 | · | · | 216,569 Direct | +17.02% | Acquired | (price as of 2026-10-02) |
| Jan. 23, 2024 | PLRX | A | 63,000 | · | · | 63,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 17, 2024 | PLRX | S 10b5-1 | 9,786 | $17.23 | $168,613 | 185,069 Direct | -5.02% | Disposed | -94.0% (price as of 2026-10-02) |
| Aug. 4, 2023 | PLRX | M | 8,791 | · | · | 31,367 Direct | -21.89% | Disposed | (price as of 2026-10-02) |
| Aug. 4, 2023 | PLRX | S 10b5-1 | 20,050 | $20.01 | $401,200 | 194,855 Direct | -9.33% | Disposed | -94.8% (price as of 2026-10-02) |
| Aug. 4, 2023 | PLRX | M | 8,791 | $2.08 | $18,285 | 214,905 Direct | +4.27% | Acquired | -50.2% (price as of 2026-10-02) |
| Aug. 3, 2023 | PLRX | M | 1,800 | · | · | 40,158 Direct | -4.29% | Disposed | (price as of 2026-10-02) |
| Aug. 3, 2023 | PLRX | S 10b5-1 | 1,800 | $20.00 | $36,000 | 206,114 Direct | +0.88% | Acquired | -94.8% (price as of 2026-10-02) |
| Aug. 3, 2023 | PLRX | M | 1,800 | $2.08 | $3,744 | 207,914 Direct | +0.87% | Acquired | -50.2% (price as of 2026-10-02) |
| Aug. 3, 2023 | PLRX | S 10b5-1 | 13,069 | $20.00 | $261,380 | 206,114 Direct | -5.96% | Disposed | -94.8% (price as of 2026-10-02) |
| July 17, 2023 | PLRX | S 10b5-1 | 17,937 | $18.01 | $323,045 | 219,183 Direct | -7.56% | Disposed | -94.3% (price as of 2026-10-02) |
| July 14, 2023 | PLRX | A | 35,156 | · | · | 237,120 Direct | +17.41% | Acquired | (price as of 2026-10-02) |
| March 30, 2023 | PLRX | S 10b5-1 | 9,036 | $26.52 | $239,635 | 201,964 Direct | -4.28% | Disposed | -96.1% (price as of 2026-10-02) |
| March 29, 2023 | PLRX | A | 17,578 | · | · | 211,000 Direct | +9.09% | Acquired | (price as of 2026-10-02) |
| Jan. 25, 2023 | PLRX | A | 76,200 | · | · | 76,200 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 25, 2023 | PLRX | A | 54,000 | · | · | 192,191 Direct | +39.08% | Acquired | (price as of 2026-10-02) |
| Dec. 20, 2022 | PLRX | S | 8,748 | $19.10 | $167,087 | 138,191 Direct | -5.95% | Disposed | -94.6% (price as of 2026-10-02) |
| Dec. 19, 2022 | PLRX | A | 17,578 | · | · | 146,939 Direct | +13.59% | Acquired | (price as of 2026-10-02) |
| Jan. 26, 2022 | PLRX | A | 112,500 | · | · | 112,500 Direct | · | Acquired | (price as of 2026-10-02) |
| May 26, 2021 | PLRX | M | 4,500 | · | · | 12,979 Direct | -25.75% | Disposed | (price as of 2026-10-02) |
| May 26, 2021 | PLRX | M | 4,500 | $2.08 | $9,360 | 125,246 Direct | +3.73% | Acquired | -50.2% (price as of 2026-10-02) |
| Jan. 23, 2021 | PLRX | A | 62,250 | · | · | 62,250 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 30, 2020 | PLRX | M | 3,500 | · | · | 17,479 Direct | -16.68% | Disposed | (price as of 2026-10-02) |
| Dec. 30, 2020 | PLRX | M | 3,500 | $2.08 | $7,280 | 120,746 Direct | +2.99% | Acquired | -50.2% (price as of 2026-10-02) |
| June 5, 2020 | PLRX | C | 27,322 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-02) |
| June 5, 2020 | PLRX | C | 36,319 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 5, 2020 | PLRX | C | 3,821 | · | · | 3,821 Indirect | · | Acquired | (price as of 2026-10-02) |
| June 5, 2020 | PLRX | C | 5,079 | · | · | 117,246 Direct | +4.53% | Acquired | (price as of 2026-10-02) |
| March 31, 2020 | PLRX | A | 70,352 | · | · | 70,352 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2020 | PLRX | A | 27,322 | $13.08 | $357,372 | 27,322 Indirect | · | Acquired | -92.1% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 23, 2025 | PLRX | Stock Option (Right to Buy) | Common Stock | $11.14 | Jan. 23, 2035 | 80,300 | Acquired |
| Jan. 23, 2024 | PLRX | Stock Option (Right to Buy) | Common Stock | $17.44 | Jan. 23, 2034 | 63,000 | Acquired |
| Aug. 4, 2023 | PLRX | Common Stock (Right to Buy) | Common Stock | $2.08 | March 31, 2028 | 8,791 | Disposed |
| Aug. 3, 2023 | PLRX | Common Stock (Right to Buy) | Common Stock | $2.08 | March 31, 2028 | 1,800 | Disposed |
| Jan. 25, 2023 | PLRX | Stock Option (right to buy) | Common Stock | $34.65 | Jan. 24, 2033 | 76,200 | Acquired |
| Jan. 26, 2022 | PLRX | Stock Option (right to buy) | Common Stock | $11.86 | Jan. 25, 2032 | 112,500 | Acquired |
| May 26, 2021 | PLRX | Stock Option (right to buy) | Common Stock | $2.08 | Jan. 23, 2029 | 4,500 | Disposed |
| Jan. 23, 2021 | PLRX | Stock Option (right to buy) | Common Stock | $26.50 | Jan. 22, 2031 | 62,250 | Acquired |
| Dec. 30, 2020 | PLRX | Stock Option (right to buy) | Common Stock | $2.08 | Jan. 23, 2029 | 3,500 | Disposed |
| June 5, 2020 | PLRX | Series C Preferred Stock | Common Stock | · | · | 27,322 | Disposed |
| June 5, 2020 | PLRX | Series B Preferred Stock | Common Stock | · | · | 36,319 | Disposed |
| March 31, 2020 | PLRX | Stock Option (right to buy) | Common Stock | · | March 30, 2030 | 70,352 | Acquired |
| Feb. 28, 2020 | PLRX | Series C Preferred Stock | Common Stock | · | · | 27,322 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 2, 2020 | PLRX | Common Stock | 112,167 | Direct |
| June 2, 2020 | PLRX | Common Stock | 13,985 | Indirect |
| June 2, 2020 | PLRX | Common Stock | 13,985 | Indirect |
| June 2, 2020 | PLRX | Series B Preferred Stock | 5,079 | Direct |
| June 2, 2020 | PLRX | Series C Preferred Stock | 3,821 | Indirect |
| June 2, 2020 | PLRX | Stock Option (right to buy) | 20,979 | Direct |
| June 2, 2020 | PLRX | Stock Option (right to buy) | 41,958 | Direct |
| June 2, 2020 | PLRX | Stock Option (right to buy) | 70,352 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $444,392 | · | · | · | $195,532 | · | $14,600 | $2,015,324 |
| 2023 | $427,300 | · | · | · | $170,920 | · | $4,293 | $4,357,277 |
| 2022 | $407,000 | · | · | · | $211,640 | · | $13,000 | $3,154,751 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.